People: Acorda Therapeutics Inc (ACOR.O)

ACOR.O on Nasdaq

36.81USD
26 Nov 2014
Price Change (% chg)

$0.31 (+0.85%)
Prev Close
$36.50
Open
$36.46
Day's High
$36.84
Day's Low
$36.12
Volume
370,286
Avg. Vol
711,718
52-wk High
$39.94
52-wk Low
$27.51

Search Stocks

Wasman, Jane 

Brief Biography

Ms. Jane Wasman, J.D., is President - International, General Counsel, Corporate Secretary of Acorda Therapeutics, Inc. Prior to that, from January 2012 until October 2012, she was our Chief, Strategic Development, General Counsel and Corporate Secretary; and from May 2004 until January 2012, she was our Executive Vice President, General Counsel and Corporate Secretary. From 1995 to 2004, Ms. Wasman held various leadership positions at Schering-Plough Corporation, including Staff Vice President and Associate General Counsel responsible for legal support for U.S. Pharmaceuticals operations, including sales, marketing and compliance; FDA regulatory matters; and global research and development. She served as Staff Vice President, International in 2001 and as Staff Vice President, European Operations-Legal from 1998 to 2000. Previously, Ms. Wasman specialized in litigation at Fried, Frank, Harris, Shriver & Jacobson. She also served as Associate Counsel to the U.S. Senate Committee on Veteran’s Affairs. Ms. Wasman graduated Magna Cum Laude and Phi Beta Kappa from Princeton University and earned her J.D. from Harvard Law School. Ms. Wasman is a member of the board of directors and the executive committee of the board of the New York Biotechnology Association (NYBA).

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
820,192 -- 996,511 2,159,620

Options Compensation

  Quantity Market Value
Exercisable 11,193 43,205.00
Unexercisable 33,576 129,603.00
Exercised 3,500 89,945.00
Name Fiscal Year Total

Ron Cohen

3,918,020

Michael Rogers

4,352,770

Lauren Sabella

1,060,110

Andrew Blight

1,484,560

Jane Wasman

2,159,620

Enrique Carrazana

1,618,840
As Of 30 Dec 2013
Search Stocks